肾移植后癌症研究更新
本文综述了肾移植受者(KTR)癌症风险增高的现状。与普通人群相比,KTR的癌症风险增加2至3倍,涉及多种癌症类型,部分与慢性肾脏病(CKD)相关,部分与致癌病毒相关。目前缺乏免疫抑制剂调整的标准方案,癌症监测和基于个体风险的个性化管理是改善预后的关键策略。
要点
- 肾移植受者癌症风险比普通人群高2-3倍,需加强监测。
- 癌症类型包括CKD相关(肾、尿路、甲状腺)和病毒相关(非霍奇金淋巴瘤、宫颈癌、非黑色素瘤皮肤癌、卡波西肉瘤)。
- 免疫抑制剂调整无标准方案,需平衡排斥风险与癌症进展。
核心结论
- 肾移植受者癌症风险显著增加,需个性化监测和管理。
研究设计与样本
- 综述,总结肾移植后癌症的流行病学、风险因素和管理策略。
主要发现
- 肾移植受者癌症风险比普通人群增加2至3倍。
- 风险涵盖CKD相关癌症和致癌病毒相关癌症。
- 免疫抑制剂调整无标准方案,需权衡排斥风险。
关键数值与推荐
- 肾移植受者癌症风险增加2至3倍(对比普通人群)。
- 癌症类型包括肾癌、尿路癌、甲状腺癌、非霍奇金淋巴瘤、宫颈癌、非黑色素瘤皮肤癌和卡波西肉瘤。
临床怎么用
- 对肾移植受者进行癌症监测,基于个体风险、预期寿命和合并症制定个性化方案。
局限性
- 缺乏免疫抑制剂调整的标准方案,需个体化决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The emergence of onconephrology in recent years highlights the importance of the interaction between kidney disease and cancer. Chronic kidney disease (CKD) and cancer are linked with each other in different ways bidirectionally: cancer can cause CKD, whereas CKD itself may be a risk factor for cancer. Kidney transplant recipients (KTRs) have a 2- to 3-fold increased cancer risk when compared with the general population. The elevated risk covers a wide range of cancers. Some are related to CKD, including cancers of the kidney, urinary tract and thyroid, whereas others are related to oncogenic viruses that include non-Hodgkin lymphoma, cervical cancer, nonmelanoma skin cancer and Kaposi's sarcoma. There is no standard protocol regarding how immunosuppressive drugs should be adjusted in patients who develop posttransplant cancers. However, any modification of immunosuppressive regimens should be balanced against the risk of allograft rejection or deterioration in kidney function. Cancer surveillance can be used as a strategy to improve the clinical outcome in KTRs. Although guidelines adopted in the general population have been used as the reference, a personalized approach based on individual cancer risk, life expectancy and concurrent comorbidities has to be adopted.
引用
- Cheung CY, Tang SCW. An update on cancer after kidney transplantation. Nephrol Dial Transplant. 2019. PMID: 30260424. doi:10.1093/ndt/gfy262
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。